Beijing Tiantan Hospital, Beijing, China
A Patient-Focused Guide to Neurosurgery, Brain Tumors and Cancer Care
The Core Question for Every Patient
If you are considering Beijing Tiantan Hospital for a brain tumor, neurosurgical cancer, or another complex neurological condition, the important question is not simply whether Tiantan is a famous hospital.
The more useful question is:
"Does Tiantan have the right specialty, surgical expertise, diagnostic resources, and treatment pathway for this particular case?"
Beijing Tiantan Hospital at a Glance
| Item | Information |
|---|---|
| Hospital | Beijing Tiantan Hospital, Capital Medical University |
| City | Beijing, China |
| Founded | 1956 |
| Hospital type | Large tertiary general hospital |
| Core institutional strength | Neuroscience and neurosurgery |
| Key cancer relevance | Brain tumors, skull-base tumors, glioma, pituitary tumors, spinal tumors and metastatic brain tumors |
| Neurosurgical research | Beijing Neurosurgical Institute |
| International services | International Medical Center |
| International service languages | English, French, Japanese and Russian are listed by Beijing Municipal Government |
| Current International Medical Center address | 119 South Fourth Ring West Road, Fengtai District, Beijing |
| Main decision point | Hospital / specialty selection |
The hospital states that it was founded in 1956 and has more than 30 clinical departments. Its institutional identity is particularly associated with neuroscience and neurosurgery.
Why Patients Consider Tiantan for Brain Tumors
Beijing Tiantan Hospital is particularly relevant when the central clinical question involves the brain, skull base, spinal cord, or another complex neurological condition.
Its Neurosurgery Center describes specialized programs covering:
- Brain tumors
- Brainstem tumors
- Skull-base tumors
- Gliomas
- Meningiomas
- Pituitary adenomas
- Pediatric neurosurgery
- Spinal tumor surgery
- Neurovascular disease
- Stereotactic and functional neurosurgery
- Epilepsy surgery
Why this matters: Some brain-tumor decisions depend heavily on the relationship between:
tumor location → neurological function → surgical accessibility → imaging → pathology → molecular findings → postoperative treatment
A hospital with a strong neuroscience infrastructure can therefore be relevant for cases where the main decision is not simply "which chemotherapy should I receive?" but rather:
"Can this tumor be safely operated on, and what should happen before and after surgery?"
Is Tiantan Mainly a Cancer Hospital?
No. This distinction matters.
Unlike a dedicated cancer hospital whose institutional mission is centered primarily on oncology, Beijing Tiantan Hospital is a general tertiary hospital with a distinctive neuroscience and neurosurgery focus.
That makes Tiantan particularly relevant for:
🧠 Brain tumors
🧠 Complex intracranial tumors
🧠 Skull-base tumors
🧠 Pituitary tumors
🧠 Brainstem tumors
🧠 Gliomas
🧠 Meningiomas
🧸 Pediatric brain tumors
🧠 Spinal tumors
Important: This does not mean that Tiantan is automatically the right destination for every cancer patient. For cancers outside the neurological system, another specialized cancer center may be more directly aligned with the patient's needs.
The Key Decision: What Does Your Brain Tumor Need?
Before selecting Tiantan, identify the main clinical question.
Is surgery being considered?
- • Where is the tumor located?
- • Is it near critical functional areas?
- • Is it close to major blood vessels?
- • What does the current MRI show?
Is the diagnosis uncertain?
Then pathology and imaging review may be more important than immediately discussing surgery.
Has the tumor returned after treatment?
Is repeat surgery appropriate, or should another treatment pathway be considered?
Is the tumor progressing after treatment?
A multidisciplinary assessment may be more useful than approaching the case as a simple surgical referral.
Brain Tumor Programs at Tiantan
Glioma
Tiantan's published neurosurgical information describes a dedicated glioma treatment subdivision. The program reports comprehensive treatment approaches including surgery, radiotherapy, chemotherapy and immunotherapy for selected patients. The hospital states that more than 700 patients are treated annually in this subdivision.
For an international patient with glioma, the more important question is:
"What is the exact pathology and molecular classification of the tumor, and what treatment decision is being considered now?"
Skull-Base and Brainstem Tumors
Tumors located around the skull base or brainstem can create a different surgical decision from tumors in more accessible areas of the brain. Tiantan's Neurosurgery Center identifies brainstem and skull-base tumors among its neurosurgical areas of excellence.
Ask specifically:
• Which team reviews skull-base or brainstem tumors?
• What imaging is required?
• Will the case be reviewed by a multidisciplinary team?
• What is the surgical objective?
• What neurological functions are at risk?
Pituitary Tumors
Tiantan's published neurosurgical information identifies a dedicated pituitary adenoma treatment subdivision. The hospital reports that individualized treatment plans may include surgery, chemotherapy and radiotherapy depending on tumor subtype and patient needs.
For a patient with a pituitary tumor, the assessment should also consider:
Hormonal function · Visual-field impairment · Tumor size · Relationship to the optic apparatus · Cavernous sinus involvement · Previous surgery · Previous radiation · Current endocrine treatment
Meningioma
Meningiomas can range from relatively straightforward tumors to lesions involving the skull base, major venous structures or critical neurological areas. Tiantan's neurosurgical programs include meningioma surgery and skull-base tumor expertise.
The useful question:
"Which anatomical and functional factors make this particular meningioma suitable for surgery, observation, radiosurgery, or another approach?"
Brain Metastases
The hospital's neurosurgical information also describes experience with metastatic brain tumors and a radiotherapy center using Gamma Knife radiosurgery.
For brain metastases, a meaningful evaluation may require:
Primary cancer diagnosis · Current systemic treatment · Number and size of brain lesions · Location · Neurological symptoms · Previous radiation · Molecular or biomarker information · Disease elsewhere in the body
Gamma Knife and Radiation: What Patients Should Understand
Tiantan's published Neurosurgery Center information states that Gamma Knife radiosurgery has been used since 1994 and describes its use for conditions including pituitary adenomas, acoustic neuromas, skull-base meningiomas and brain metastatic tumors. Conventional radiotherapy is also available.
But the existence of Gamma Knife does not mean that every brain tumor should receive Gamma Knife.
Before choosing a radiosurgical pathway, ask:
- What is the exact diagnosis?
- What is the size and location of the lesion?
- Is the lesion solitary or multiple?
- Has it been previously irradiated?
- What neurological structures are nearby?
- Why is radiosurgery preferred over surgery or conventional radiation?
- What follow-up imaging is required?
The technology is one part of the decision. Patient selection is the more important part.
What Makes Tiantan Different From a General Cancer Center?
For a patient with a brain tumor, Tiantan's main potential advantage is the depth of its neuroscience ecosystem.
The hospital describes its Neurosurgery Center as a major national neurosurgical center, while the Beijing Neurosurgical Institute supports research in areas including microanatomy, neurobiology, neural injury and repair, neural stem cells and cerebrovascular disease.
This can be particularly relevant when a case requires highly specialized neurological decision-making.
When Tiantan May Be Worth Investigating
🧠 The main problem is a brain tumor
Especially when the tumor requires specialized neurosurgical assessment.
🧠 The tumor is anatomically complex
For example, skull-base, brainstem or deep intracranial lesions.
⚖️ Surgery is a major decision
Particularly when the balance between tumor removal and neurological function is central.
🔄 A second surgical opinion is needed
Especially after an initial recommendation for surgery elsewhere.
🔄 The tumor has returned
A recurrent tumor may require reassessment of surgery, radiation, systemic treatment or a combination.
🧠 A multidisciplinary neurological pathway is needed
Cases involving neurosurgery, imaging, pathology and radiation may benefit from coordinated evaluation.
When Another Hospital May Be More Appropriate
Tiantan's reputation in neurosurgery should not automatically determine the destination.
Another center may be more appropriate when:
🫁 The cancer is not primarily neurological
A patient seeking treatment for pancreatic, liver, breast or colorectal cancer may benefit more directly from a specialized oncology center focused on that disease.
💊 The main objective is systemic therapy
A dedicated oncology center may provide a more directly relevant pathway for chemotherapy, targeted therapy or immunotherapy.
🧪 A specific clinical trial is the priority
Trial eligibility, recruitment status and study criteria should be evaluated individually.
🏥 The patient requires a treatment available only at another center
Hospital selection should follow treatment access requirements rather than reputation.
International Medical Center
For international patients, Tiantan has an International Medical Center.
Address: 119 South Fourth Ring West Road, Fengtai District, Beijing
Service languages listed by Beijing Municipal Government: English, French, Japanese and Russian.
The center is described as a comprehensive clinic with neuroscience as its major specialty and includes neurosurgery, neurology, neuropsychology and neurological intervention, with multi-department consultations available.
Important: The international pathway is not necessarily identical to the standard domestic registration pathway. Confirm the current appointment procedure directly before travelling.
International Neurosurgery Services
Tiantan's international neurosurgical wards report treatment of conditions including:
- • Gliomas
- • Skull-base tumors
- • Brainstem tumors
- • Deep intracranial tumors
- • Meningiomas
- • Pituitary adenomas
- • Acoustic neuromas
- • Craniopharyngiomas
- • Cerebrovascular disease
- • Metastatic tumors
The hospital's international department also describes the use of multimodal imaging before surgery and intraoperative ultrasound, navigation and electrophysiological monitoring.
For a patient considering international treatment, these details are useful because they show that Tiantan has a dedicated international pathway rather than requiring every foreign patient to navigate the hospital entirely through the standard domestic route.
What Medical Records Should You Send?
For a brain tumor referral, send a structured case, not simply a folder of unrelated documents.
Essential
- • Pathology report
- • MRI brain report
- • Original MRI images / DICOM when available
- • Previous surgical report
- • Previous radiation records
- • Chemotherapy or systemic treatment history
- • Current medications
- • Recent laboratory results
Particularly important for complex tumors
- • Molecular pathology
- • Immunohistochemistry
- • Genetic / genomic findings
- • Previous radiotherapy plan
- • Previous MRI comparison studies
The Most Useful One-Page Summary
Before contacting Tiantan, prepare:
Diagnosis: Exact tumor type and pathology
Location: Brain region / skull base / brainstem / spine
Date diagnosed: When the diagnosis was established
Molecular findings: Relevant biomarkers and molecular classification
Previous treatment: Surgery / radiation / chemotherapy / targeted therapy / immunotherapy
Current status: Stable / responding / recurrent / progressing
Latest MRI: Date + key findings
Neurological status: Important symptoms or functional limitations
Main clinical question:
"Is this recurrent glioma potentially suitable for another surgical evaluation?"
rather than:
"What treatment do you offer for brain cancer?"
Why this matters: A hospital can respond much more meaningfully to a specific clinical question than to a general inquiry about treatment availability.
Before Travelling to Beijing
Do not book international travel solely because an online page says that Tiantan specializes in brain tumors.
First confirm:
- Department — Which exact department or specialist team should review the case?
- Record review — Has the hospital actually reviewed the patient's records?
- Appointment — Is the appointment confirmed?
- Diagnostic requirements — Are original MRI files, pathology slides or tissue blocks required?
- Treatment status — Has the hospital only agreed to evaluate the patient, or has it discussed a possible treatment pathway? These are not the same thing.
- Additional testing — Which tests may need to be repeated in Beijing?
- Cost — What is included in the initial assessment and what is charged separately?
- Hospitalization — If surgery is recommended, what is the expected admission process?
- Language — Who will assist with medical communication and consent?
- Follow-up — How will postoperative or post-treatment follow-up be handled after the patient returns home?
Cost: Why a Single Price Is Not Useful
There is no meaningful universal "Tiantan brain tumor treatment cost."
The final amount may depend on:
- • Diagnosis
- • Tumor location
- • Surgical complexity
- • Diagnostic testing
- • Pathology review
- • Imaging
- • Operating-room requirements
- • ICU needs
- • Hospital stay
- • Radiation
- • Medications
- • Complications and follow-up
For international patients, also consider:
Ask for a written estimate that clearly distinguishes:
hospital charges + diagnostics + treatment + medications + accommodation-related costs + additional possible charges.
Questions to Ask Tiantan Before Accepting a Treatment Plan
Clinical
- What is the exact diagnosis?
- Has the pathology been reviewed?
- Does the MRI need to be reviewed again?
- Which department will manage the case?
- Is the case suitable for multidisciplinary review?
Surgery
- What is the objective of surgery?
- What neurological functions are potentially at risk?
- Is the goal complete removal, maximal safe resection, biopsy, decompression, or another objective?
- What alternatives exist if surgery is not recommended?
Radiation
- Is stereotactic radiosurgery appropriate?
- Why is it preferred over conventional radiation or surgery?
Systemic treatment
- Is additional systemic therapy relevant?
- Are molecular tests needed before choosing treatment?
Clinical trials
- Are there currently recruiting studies relevant to this diagnosis?
- What are the inclusion and exclusion criteria?
- Are international patients eligible?
Logistics
- What documents must be submitted before arrival?
- Which international-patient pathway should be used?
- What payment and deposit requirements apply?
- What follow-up will be available after returning home?
Tiantan vs. a Dedicated Cancer Hospital
| Decision factor | Beijing Tiantan Hospital | Dedicated Cancer Hospital |
|---|---|---|
| Neurosurgery | Core institutional strength | Depends on center |
| Brain tumors | Strong relevance | Depends on center |
| Skull-base tumors | Highly relevant | Center-dependent |
| Neurovascular expertise | Major focus | Usually not the central focus |
| General oncology | Available within a large hospital | Often a core institutional mission |
| Pathology | Relevant to neurological disease | Often extensive across cancer types |
| Radiation | Available | Often central to oncology pathway |
| Systemic cancer treatment | Available | Often broader cancer-specific infrastructure |
| International services | Dedicated International Medical Center | Depends on hospital |
| Best use case | Complex neurological / neurosurgical decisions | Broader oncology decisions |
The correct interpretation is not: "Tiantan is better than a cancer hospital."
It is: "Tiantan may be particularly relevant when the patient's cancer decision is primarily neurological or neurosurgical."
A Practical Decision Filter
Before choosing Tiantan, ask:
The Bottom Line
Beijing Tiantan Hospital is most relevant to international cancer patients when the central clinical problem involves the brain, spinal cord, or another complex neurological condition.
Its major distinction is not simply that it is a large hospital in Beijing. It is the combination of:
But the correct sequence is:
Diagnosis → Pathology → MRI → Tumor location → Current treatment status → Clinical question → Relevant specialty → Hospital selection
—not—
Famous hospital → travel → ask what treatment is available.
That distinction can save patients time, unnecessary travel and poorly targeted hospital inquiries.
Frequently Asked Questions
Tiantan has a major institutional focus on neuroscience and neurosurgery and publishes dedicated programs for brain tumors, glioma, skull-base tumors, pituitary tumors and other neurological conditions. Whether it is appropriate for a specific patient depends on the diagnosis, tumor location, previous treatment and clinical question.
No. It is a large tertiary general hospital with a distinctive neuroscience and neurosurgery focus.
Yes. The hospital describes a dedicated glioma treatment subdivision with surgery and other treatment modalities for selected patients.
Yes. Its published neurosurgical programs include meningioma and pituitary adenoma treatment.
Yes, Tiantan has an International Medical Center. Beijing Municipal Government information lists English, French, Japanese and Russian among its service languages.
The hospital's published Neurosurgery Center information describes Gamma Knife radiosurgery and its use in selected tumor types.
No. The treatment modality must first be appropriate for the patient's diagnosis, tumor size, location, previous treatment and overall clinical situation.
Official Information
Beijing Tiantan Hospital
Capital Medical University, Beijing, China
International Medical Center: 119 South Fourth Ring West Road, Fengtai District, Beijing
Service languages: English, French, Japanese and Russian
Hospital information, departments, appointment procedures, clinical-trial availability, prices and international-patient policies can change. Confirm current details directly with the hospital before making treatment or travel decisions.
Last reviewed: August 2026
Continue Your Research
🇨🇳 China Access Guide
Complete guide to cancer treatment access in China.
Explore China →🧪 Clinical Trials Guide
Understand trial phases, eligibility and how to evaluate a trial.
Clinical Trials Guide →📊 Treatment Outcomes
Understand response rates, survival and evidence interpretation.
Treatment Outcomes →📋 Get a Second Opinion
Submit your case for an independent evidence review.
Explore Options →